Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert


Search Title by author or title

Why should SLT be the first-choice treatment for glaucoma?

Poster Details

First Author: M.Abdelmseih GERMANY

Co Author(s):                        

Abstract Details


SLT as primary treatment is a safe and effective procedure in various types of glaucoma, including primary open-angle glaucoma (POAG), Ocular Hypertension, normal-tension glaucoma (NTG), pseudoexfoliation glaucoma (PXFG), steroid-induced glaucoma


Augenärzte am Meer Clinic , Germany


Meta-analysis of many studies showed that there was no statistically significant difference in IOP-reduction or treatment success between SLT and medical treatment.


As a first-line therapy for glaucoma, medications have many disadvantages and drawbacks. In the initial released research, SLT was used as the adjunct treatment to medication. Later several researches had recommended that SLT might be the main treatment for POAG or OHT. SLT has been proven secure, well recognized, low-cost and very efficient at reducing intraocular pressure (IOP) as primary treatment in several types of glaucomas. Furthermore, SLT can be regarded as a primary treatment choice for patients who cannot accept or who are non-compliant with their glaucoma medications.


SLT is easy to perform and well tolerated by patients and provides the benefits of ALT while using much less energy with less obvious harm to the TM. It seems to have comparative effectiveness to eye drops and to be a safe and effective glaucoma treatment without conformity threats or widespread adverse reactions. Therefore, SLT is now considered the first line therapy for various types of glaucoma and can be an effective adjunct in the early types of glaucoma.

Financial Disclosure:


Back to Poster listing